|
1
|
Grivennikov SI and Karin M: Inflammation
and oncogenesis: A vicious connection. Curr Opin Genet Dev.
20:65–71. 2010. View Article : Google Scholar :
|
|
2
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akhurst RJ and Hata A: Targeting the TGFβ
signalling pathway in disease. Nat Rev Drug Discov. 11:790–811.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Das P and Golde T: Dysfunction of TGF-beta
signaling in Alzheimer's disease. J Clin Invest. 116:2855–2857.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jou J and Diehl AM: Epithelial-mesenchymal
transitions and hepatocarcinogenesis. J Clin Invest. 120:1031–1034.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Savagner P: The epithelial-mesenchymal
transition (EMT) phenomenon. Ann Oncol. 21(Suppl 7): vii89–vii92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun XD, Liu XE and Huang DS: Curcumin
reverses the epithelial-mesenchymal transition of pancreatic cancer
cells by inhibiting the Hedgehog signaling pathway. Oncol Rep.
29:2401–2407. 2013.PubMed/NCBI
|
|
11
|
Kim YH, Kim G, Kwon CI, Kim JW, Park PW
and Hahm KB: TWIST1 and SNAI1 as markers of poor prognosis in human
colorectal cancer are associated with the expression of ALDH1 and
TGF-β1. Oncol Rep. 31:1380–1388. 2014.PubMed/NCBI
|
|
12
|
Yeh YH, Yang YC, Hsieh MY, Yeh YC and Li
TK: A negative feedback of the HIF-1α pathway via
interferon-stimulated gene 15 and ISGylation. Clin Cancer Res.
19:5927–5939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chaudhry P, Fabi F, Singh M, Parent S,
Leblanc V and Asselin E: Prostate apoptosis response-4 mediates
TGF-β-induced epithelial-to-mesenchymal transition. Cell Death Dis.
5:e10442014. View Article : Google Scholar
|
|
14
|
Huang J, Yao X, Zhang J, Dong B, Chen Q,
Xue W, Liu D and Huang Y: Hypoxia-induced downregulation of miR-30c
promotes epithelial-mesenchymal transition in human renal cell
carcinoma. Cancer Sci. 104:1609–1617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bakin AV, Tomlinson AK, Bhowmick NA, Moses
HL and Arteaga CL: Phosphatidylinositol 3-kinase function is
required for transforming growth factor beta-mediated epithelial to
mesenchymal transition and cell migration. J Biol Chem.
275:36803–36810. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang HY, Wang ZQ, Li YY, Wang F, Zeng QR,
Gao Y, Xuan XY and Li SS: Transforming growth factor-β1-induced
epithelial-mesenchymal transition in human esophageal squamous cell
carcinoma via the PTEN/PI3K signaling pathway. Oncol Rep.
32:2134–2142. 2014.PubMed/NCBI
|
|
18
|
Zhang YE: Non-Smad pathways in TGF-beta
signaling. Cell Res. 19:128–139. 2009. View Article : Google Scholar :
|
|
19
|
Brandl M, Seidler B, Haller F, Adamski J,
Schmid RM, Saur D and Schneider G: IKK(α) controls canonical
TGF(β)-SMAD signaling to regulate genes expressing SNAIL and SLUG
during EMT in panc1 cells. J Cell Sci. 123:4231–4239. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin Y, Dong C and Zhou BP: Epigenetic
regulation of EMT: The Snail story. Curr Pharm Des. 20:1698–1705.
2014. View Article : Google Scholar :
|
|
21
|
Kitagishi Y, Kobayashi M, Kikuta K and
Matsuda S: Roles of PI3K/AKT/GSK3/mTOR pathway in cell signaling of
mental illnesses. Depress Res Treat. 2012:7525632012.
|
|
22
|
Shiojima I and Walsh K: Regulation of
cardiac growth and coronary angiogenesis by the Akt/PKB signaling
pathway. Genes Dev. 20:3347–3365. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aberle H, Bauer A, Stappert J, Kispert A
and Kemler R: Beta-catenin is a target for the ubiquitin-proteasome
pathway. EMBO J. 16:3797–3804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McCubrey JA, Steelman LS, Bertrand FE,
Davis NM, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F,
Maestro R, et al: Multifaceted roles of GSK-3 and Wnt/β-catenin in
hematopoiesis and leukemogenesis: Opportunities for therapeutic
intervention. Leukemia. 28:15–33. 2014. View Article : Google Scholar :
|
|
25
|
Shtutman M, Zhurinsky J, Simcha I,
Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1
gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad
Sci USA. 96:5522–5527. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Blobe GC, Schiemann WP and Lodish HF: Role
of transforming growth factor beta in human disease. N Engl J Med.
342:1350–1358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Padua D and Massagué J: Roles of TGFbeta
in metastasis. Cell Res. 19:89–102. 2009. View Article : Google Scholar
|
|
29
|
Son H and Moon A: Epithelial-mesenchymal
transition and cell invasion. Toxicol Res. 26:245–252. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer-related inflammation, the seventh hallmark
of cancer: Links to genetic instability. Carcinogenesis.
30:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng XM, Tang PM, Li J and Lan HY:
TGF-β/Smad signaling in renal fibrosis. Front Physiol. 6:822015.
View Article : Google Scholar
|
|
33
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang
C, Xie S, Chen C, Hu L, Xu S, et al: Wnt/β-catenin signaling
enhances hypoxia-induced epithelial-mesenchymal transition in
hepatocellular carcinoma via crosstalk with hif-1α signaling.
Carcinogenesis. 34:962–973. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jiang BH and Liu LZ: PI3K/PTEN signaling
in angiogenesis and tumorigenesis. Adv Cancer Res. 102:19–65. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Agani F and Jiang BH: Oxygen-independent
regulation of HIF-1: Novel involvement of PI3K/AKT/mTOR pathway in
cancer. Curr Cancer Drug Targets. 13:245–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jung YJ, Isaacs JS, Lee S, Trepel J and
Neckers L: IL-1beta-mediated up-regulation of HIF-1alpha via an
NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between
inflammation and oncogenesis. FASEB J. 17:2115–2117.
2003.PubMed/NCBI
|
|
38
|
Kasuno K, Takabuchi S, Fukuda K,
Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL and Hirota K: Nitric
oxide induces hypoxia-inducible factor 1 activation that is
dependent on MAPK and phosphatidylinositol 3-kinase signaling. J
Biol Chem. 279:2550–2558. 2004. View Article : Google Scholar
|
|
39
|
Laughner E, Taghavi P, Chiles K, Mahon PC
and Semenza GL: HER2 (neu) signaling increases the rate of
hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel
mechanism for HIF-1-mediated vascular endothelial growth factor
expression. Mol Cell Biol. 21:3995–4004. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of Snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
